Le Lézard
Classified in: Health
Subject: SVY

Antithrombin Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2017 - 2025


LONDON, Nov. 20, 2017 /PRNewswire/ --

Global Antithrombin Market ? Overview

This report on antithrombin market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, providing services of antithrombin products such as Antithrombin III, ATryn, and Antithrombin Gama and others as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the overall information and data analysis of the global antithrombin market with respect to the leading market segments based on major application segment, source segment, and dosage form segment.



Download the full report: https://www.reportbuyer.com/product/5207227



Global Antithrombin Market: Market Segmentation

Based on the application type, the antithrombin market has been segmented into: therapeutics, research and diagnostics. Each of the market segments have been extensively analyzed based on the market related factors such as increasing demand of antithrombin products worldwide, and technological advancement. Moreover, historical year-on-year growth have been taken into consideration while estimating the market size. The market size and forecast in terms of US$ million for each segment has been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.

Geographically, antithrombin market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Rest of World. The market size and forecast for each of these regions has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The report also provides with market size and forecast for major countries in the respective regions. A detailed qualitative analysis of factors responsible for driving and restraining the market growth and future opportunities has been provided in the market overview section. This section of the report also provides with market attractiveness analysis, Porter's five forces analysis, and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global antithrombin market.

Global Antithrombin Market: Market Dynamics

The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the antithrombin market and could influence the market in the near future. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different geographies. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global antithrombin market.

Global Antithrombin Market: Competitive Landscape

The key findings section included in the report would assist existing market players in expanding their market shares, and new companies in establishing their presence in the global antithrombin market. The report also profiles key players operating in the antithrombin market which are rEVO Biologics, Inc., Grifols, Shire plc, CSL Limited, Kedrion S.p.A, Lee Bisolutions, Inc., Scripps Laboratories, Inc., Octapharma AG, Dem ilac Inc. and Diapharma Group, Inc.

The global antithrombin market is segmented as follows:

Global Antithrombin market, by Application
Therapeutics
Research
Diagnostics

Global Antithrombin market, by Source
Human
Goat Milk
Others

Global Antithrombin market, by Dosage form
Lyophilized
Liquid

Global Antithrombin market, by Geography
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of the Europe
Asia Pacific
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America (LATAM)
Brazil
Argentina
Rest of Latin America
Rest of World

Download the full report: https://www.reportbuyer.com/product/5207227

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

 

SOURCE ReportBuyer


These press releases may also interest you

at 12:35
MapLight Therapeutics, a clinical-stage biopharmaceutical company working to develop targeted novel therapeutics to improve the lives of patients suffering from debilitating CNS...

at 12:27
This year marks the 14th anniversary of the enactment of the Affordable Care Act (ACA). Its passage was the most significant advancement of health policy since the establishment of Medicare and Medicaid in the 1960s and made healthcare accessible and...

at 12:15
ResBiotic Nutrition, Inc. (ResBiotic), the pioneering physician-developed pre/probiotic wellness scale-up, proudly announces the appointments of Stefany Nieto as Vice President of Operations and Brittany Zenner as Director of Marketing. Nieto is a...

at 12:06
Maid Sailors Cleaning Service has joined forces with Cleaning for a Reason, a non-profit organization offering free house cleaning services to cancer patients across the United States and Canada....

at 12:05
Terragia Biofuel, a technology startup aiming to drive the next generation of biofuels, today announced it has raised a $6 million seed round led by Engine Ventures and Energy Impact Partners (EIP). The company will use the capital to commercialize...

at 12:05
Float, the marketplace moving all the care that doesn't need a hospital to the home, today announced $10 million in Series A funding led by Canvas Ventures, whose General Partner Mike Ghaffary has joined Float's board, with participation from Wave...



News published on and distributed by: